BCL2 and ovarian carcinoma: The proliferation of ovarian cancer cells is considerably inhibited by berberine in a dose- and time-dependent way, and apoptosis is induced, probably via downregulation of anti-apoptotic genes survival and BCL-2, and pro-apoptotic gene BAX upregulation.